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Following the development of penicillin, complications from streptococcus pneumonia such as endocarditis have become rare.
However, certain independent risk factors such as cigarette smoking and being of African-American (AA) decent have been
associated with a higher incidence of invasive pneumococcal disease, but only cigarette smoking has been targeted by current
recommendations from the Advisory Committee on Immunological Practices (ACIPs). We report a case of a young AA smoker,
who developed an isolated tricuspid valve pneumococcal endocarditis. This case will illustrate the high susceptibility for invasive
pneumococcus sequelae in AA, thereby raising the argument for the consideration of AA in the Pneumococcal Conjugate Vaccine
(PCV) criteria, regardless of smoking history.
1.Introduction
Isolated tricuspid valve endocarditis is usually seen in
intravenous drug users and patients with abnormal or
prosthetic heart valves [1]. Since the introduction of peni-
cillin, streptococcus pneumoniae has been an uncommon
cause of bacterial endocarditis accounting for less than
5% of all the cases of endocarditis [2]. Cigarette smoking
and being of an AA ethnicity are strong independent risk
factors for invasive pneumococcal disease in the nonelderly
and immunocompetent patients [3] .T h er a t eo fi n v a s i v e
pneumococcal disease in AA of all ages has at least twice
the risk in the white population in the United States [4,
5]. Pneumococcal bacteremia could lead to complications
such as endocarditis [6]. We report a case of an isolated
tricuspid valve endocarditis due to PSSP in a nonelderly
AA chronic smoker without any other additional risk
factors.
2. Case Presentation
A 27-year-old African-American female, presented with
complaints of cough and vomiting for the past two
weeks. The patient was seen in the emergency room one
week prior with similar problems and was sent home
on oral levaﬂoxacin and ibuprophen for CAP. Despite
being on oral antibiotics, the patient did not improve
and returned to the hospital with similar complaint in
addition to a fever and a cough with whitish-yellow spu-
tum production. The patient did not report any history
of surgical, dental, or genitourinary procedures prior to
the emergence of her symptoms. She also had no his-
tory of congenital cardiac disease, systemic lupus erythe-
matosus, or rheumatic fever. She smoked one pack of
cigarettes per day for 11 years, occasionally used mari-
juana and had no history of alcohol or intravenous drug
use.2 Case Reports in Medicine
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Figure 1: This is a transthoracic echocardiogram. White arrows point to the 2.6 × 1.7cm pedunculated vegetation.
On physical exam, her temperature was 102.8F, heart
rate was 98bpm, respiratory rate was 34rpm, and her
blood pressure was 157/97mmHg. On heart auscultation,
the rhythm and rate were normal. S1 and S2 sounds were
present. There was a grade 2/6 mid-systolic murmur heard
best in the left lower sternal border, nonradiating, which
was new when compared with the previous visit to the
emergency department. The point of maximal impact (PMI)
was nondisplaced. On lung exam, faint crackles were heard
on the right side. The remaining physical examination was
within the normal limit.
The laboratory results showed a white blood cell count of
26.1k/cumm, hemoglobin 10.7g/dL, and hematocrit 31.3%.
The Urinalysis and urine drug screen was negative. Two
separate sets of blood cultures were positive for Streptococ-
cus pneumonia sensitive to penicillin (MIC < 0.03). The
Sputum culture was negative. The chest X-ray showed a
right middle lobe inﬁltrate. Trans-thoracic echocardiogram
(Figure 1) showed a 2.2 × 1.6cm pedunculated vegetation,
noted on the base of the posterior cusp of the tricuspid valve
with moderate tricuspid regurgitation. The ejection fraction
was>55%.ThediagnosisofPSSPendocarditiswasmadeand
the patient was started on IV ceftriaxone.
On the second day of admission, the patient started com-
plainingofleftpleuriticchestpain,dyspnea,andhemoptysis.
Given the fact that the patient had valvular vegetations, a
CT scan (Figure 2) was done to rule out pulmonary septic
embolism. The CT scan showed cavitary and noncavitary
small nodular lesions consistent with pulmonary septic
embolization and a lingular pneumonia. After seven days of
treatment,pyrexiapersistedandgentamicinwasaddedtothe
regimen. Patient remained afebrile for the next 72 hours and
was discharged to complete a six-week course of antibiotics.
3. Discussion
The risk for invasive pneumococcal disease has been shown
to vary between ethnic groups. Previous studies have iden-
tiﬁed African-American ethnicity as an independent risk
factor for invasive pneumococcal disease with odds ratio of
3.4 in a study by Nuorti et al. [3] and of 4.6 in a study by
Lexau et al. [4] .T h er a t eo fi n v a s i v ep n e u m o c o c c a ld i s e a s e
in AA of all ages is about twice more frequent than in
the white population in the United States [5, 6]. Although,
cigarette smoking has been noted as a strong risk factor for
invasivepneumococcaldisease,thefactthatthispatientisAA
signiﬁcantly increases her overall risk.
A mechanism to explain the etiology of endocarditis
in this young AA smoker could be that the patient had
nasopharyngealpneumococcalcolonization,whichisusually
increased in both AA and smokers [7]. Following breach
of the mucosal barriers—perhaps due to a viral infection—
the patient developed invasive disease (bacteremia), and
then secondary spread to the tricuspid valve. It is also
conceivable that the invasive pneumococcus was either
causative or as a result of the patients’ pulmonary infec-
tion. Pneumococcal bacteremia can occur in patients with
or without pneumococcal pneumonia and it can also
occur in both immunocompetent and immunosuppressed
individuals.
Most cases of isolated endocarditis of the tricuspid valve
have been associated with intravenous drug use, intracar-
diac catheterization, cardiac anomalies, immunodeﬁciency,
and indwelling central venous lines [1]. Tricuspid valve
lesions tend to be attributed to Staphylococcus infections
[8, 9] with pneumococcus being an uncommon causative
organism [10]. In a review article of 197 patients with
pneumococcalendocarditis,10patients(8.3%)hadtricuspid
valve involvement [11]. What made our patient unique
are not the individual diagnostic ﬁndings but the aggre-
gate clinical picture. This patient had isolated right heart
involvement, which is less common than left-sided lesions.
Also, the organism involved in this patient was penicillin
sensitivepneumococcus(penicillinresistantspeciesaremore
commonly reported [12, 13]). Furthermore, the patient also
lacked the common risk factors frequently associated with
tricuspid valve disease, which include chronic alcoholism
and heart valve abnormalities.Case Reports in Medicine 3
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Figure 2: White shows cavitary and non-cavitary small nodular lesions changes consistent with pulmonary septic embolization and the
black arrow shows a small left pleural eﬀusion. Black and white arrow is showed a complicated ligulae pneumonia.
Due to the fact that pneumococcal bacteremia can
lead to such serious complications such as endocarditis,
which carries signiﬁcant morbidity and mortality, it should
be treated with vigilance. The Advisory Committee on
Immunological Practices (ACIPs) recommends that Alaska
Natives and American Indians of all ages should receive
pneumococcal polysaccharide vaccine, if they are living in
area in which the risk of invasive pneumococcal diseases
is increased [14]. Current provisional recommendations do
not include African-American adults aged <65 years without
underlying illnesses. Even though we concede that this
patient would have qualiﬁed for the vaccine because she is
a smoker, we can also argue that evidence suggests she is a
candidate by virtue of simply being AA. The cumulative risk
ofbeing anAAsmokershouldbetreatedwithmorevigilance
and when these patients are identiﬁed in our clinics and
emergencyrooms.Wemustbeassertiveinencouragingthem
to receive vaccinations to prevent serious illness. PCV have
resulted in the decrease of invasive pneumococcal disease in
children, the elderly [15, 16], and should be considered for
all patients at risk for invasive pneumococcal disease, which
includes young AA.
4. Conclusion
Streptococcal pneumoniae is a rare cause of endocarditis,
which rarely aﬀects the tricuspid valve. A high index of
suspicion for bacterial endocarditis should be applied in
all patients, especially AA and smokers in the setting of
pneumococcal bacteremia. Prudent auscultation for new
murmurs in such patients must be executed judiciously. An
echocardiogram might be indicated in a patient with pneu-
mococcal pneumonia who is not responding to appropriate
antibiotics to rule out endocarditis. Finally, it is worthy of
debate that the inclusion of African Americans to the PCV
vaccination criteria be considered to prevent the occurrence
of pneumococcal bacteremia and its complications.
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